← Back to Blog

New Research on LDN for Dermatological Conditions

It seems like every month, new clinical trial results are published that demonstrate the effectiveness of low dose naltrexone for a variety of dermatological conditions. While LDN is being studied for treating everything from cervical cancer to arthritis, the field where some of the most conclusive results are being found is dermatology. Research published this year has confirmed that low dose naltrexone is an effective treatment for psoriasis, erythromelalgia, and…
Read Full Article

Low Dose Naltrexone Dosage

Low dose naltrexone is used to treat a variety of chronic conditions that often do not respond to other treatments. The drug has been getting a lot of attention lately from both prescribers and patients due to its demonstrated efficacy and safety and also its low monthly cost. However there is a lot of misinformation out there about the correct dosing for naltrexone. While the research on low dose naltrexone…
Read Full Article

LDN for Dermatological Conditions

It seems that new research demonstrating the benefits of daily low dose naltrexone (LDN) usage is published every month. Recently there have been case studies and reports showing that LDN may an effective treatment for dermatological conditions. A majority of existing treatments for these conditions are topical, making LDN a unique oral option that is non-toxic and can be used on a daily basis. LDN and Dermatology LDN (low-dose naltrexone)…
Read Full Article

Low Dose Naltrexone for Psoriasis

Currently there is no cure for psoriasis and treatment involves preventing and reducing the extent of flare-ups. Low dose naltrexone is a promising new treatment option for psoriasis. This non-toxic drug has been prescribed for many years to treat a variety of chronic conditions. Medications Available for Treating Psoriasis Commercially available medications for treating psoriasis include biologics, systemic medications like methotrexate, and topical creams. Topical creams are one of the…
Read Full Article